Clinuvel Pharmaceuticals
CUV.AX
#7296
Rank
NZ$0.59 B
Marketcap
$11.81
Share price
-0.27%
Change (1 day)
-27.96%
Change (1 year)

EPS for Clinuvel Pharmaceuticals (CUV.AX)

EPS in 2023: $0.69

According to Clinuvel Pharmaceuticals's latest financial reports the company's current EPS (TTM) is $0.69. In 2023 the company made an earnings per share (EPS) of $0.69 an increase over its 2022 EPS that were of $0.49.

EPS history for Clinuvel Pharmaceuticals from 2000 to 2023

Annual EPS

Year EPS Change
2023$0.6940.79%
2022$0.49-22.53%
2021$0.6361.74%
2020$0.39-12.03%
2019$0.4428.75%
2018$0.3479.08%
2017$0.19-318.99%
2016-$0.08768-71.6%
2015-$0.3136.75%
2014-$0.23-23.66%
2013-$0.30-45.84%
2012-$0.55-18.99%
2011-$0.6725.76%
2010-$0.54-22.24%
2009-$0.69-10.59%
2008-$0.7746.78%
2007-$0.53-34.2%
2006-$0.80-25.89%
2005-$1.0840.91%
2004-$0.7655.12%
2003-$0.4952.02%
2002-$0.3271.69%
2001-$0.19355.46%
2000-$0.04146